Center for Scientific Review; Notice of Closed Meetings, 61607 [2023-19282]

Download as PDF Federal Register / Vol. 88, No. 172 / Thursday, September 7, 2023 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; R13 Conference Grant Applications. Date: September 28, 2023. Time: 10:00 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIDDK Democracy II, Suite 7000A, 6707 Democracy Boulevard Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jian Yang, Ph.D., Scientific Review Officer, NIDDK/Scientific Review Branch, National Institutes of Health, 6707 Democracy Boulevard, Room: 7111, Bethesda, MD 20892–2542, (301) 594–7799, yangj@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: August 31, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–19263 Filed 9–6–23; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as VerDate Sep<11>2014 19:19 Sep 06, 2023 Jkt 259001 amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group Biobehavioral Medicine and Health Outcomes Study Section. Date: October 3–4, 2023. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Mark A Vosvick, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892 (301) 402– 4128. mark.vosvick@nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group, Neuroscience of Basic Visual Processes, Study Section. Date: October 4–5, 2023, Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications, Place: Melrose Hotel 2430 Pennsylvania Ave. NW, Washington, DC 20037, Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844 Bethesda, MD 20892 301–435–1242 kgt@mail.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group, Clinical Neuroimmunology and Brain Tumors Study Section. Date: October 5–6, 2023. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel 2430 Pennsylvania Ave. NW, Washington, DC 20037. Contact Person: Aleksey G Kazantsev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20817, 301–435– 1042, aleksey.kazantsev@nih.gov. PO 00000 Frm 00109 Fmt 4703 Sfmt 9990 61607 Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group, Behavioral Neuroendocrinology, Neuroimmunology, Rhythms, and Sleep Study Section. Date: October 5–6, 2023. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael Selmanoff, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD 20892, 301–435–1119, selmanom@csr.nih.gov. Name of Committee: Emerging Technologies and Training Neurosciences, Integrated Review Group, Molecular Neurogenetics Study Section. Date: October 5–6, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Mary G Schueler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD 20892, 301–915–6301, marygs@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group Genomics, Computational Biology and Technology Study Section. Date: October 5–6, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301–827– 7088, methode.bacanamwo@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846– 93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 31, 2023. David W Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–19282 Filed 9–6–23; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\07SEN1.SGM 07SEN1

Agencies

[Federal Register Volume 88, Number 172 (Thursday, September 7, 2023)]
[Notices]
[Page 61607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19282]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Risk, Prevention and Health Behavior Integrated 
Review Group Biobehavioral Medicine and Health Outcomes Study Section.
    Date: October 3-4, 2023.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark A Vosvick, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3110, Bethesda, MD 20892 (301) 402-4128. 
[email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group, Neuroscience of Basic Visual 
Processes, Study Section.
    Date: October 4-5, 2023,
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications,
    Place: Melrose Hotel 2430 Pennsylvania Ave. NW, Washington, DC 
20037,
    Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5184, MSC 7844 Bethesda, MD 20892 301-435-1242 
[email protected].

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group, Clinical Neuroimmunology and Brain Tumors 
Study Section.
    Date: October 5-6, 2023.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel 2430 Pennsylvania Ave. NW, Washington, DC 
20037.
    Contact Person: Aleksey G Kazantsev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 5201, Bethesda, MD 20817, 301-435-1042, 
[email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group, Behavioral Neuroendocrinology, 
Neuroimmunology, Rhythms, and Sleep Study Section.
    Date: October 5-6, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Selmanoff, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD 20892, 301-435-
1119, [email protected].

    Name of Committee: Emerging Technologies and Training 
Neurosciences, Integrated Review Group, Molecular Neurogenetics Study 
Section.
    Date: October 5-6, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mary G Schueler, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD 20892, 301-915-6301, 
[email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated Review 
Group Genomics, Computational Biology and Technology Study Section.
    Date: October 5-6, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Methode Bacanamwo, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301-827-7088, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 31, 2023.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-19282 Filed 9-6-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.